Literature DB >> 1855681

Impaired intestinal barrier function measured by differently sized polyethylene glycols in patients with chronic renal failure.

M Magnusson1, K E Magnusson, T Sundqvist, T Denneberg.   

Abstract

The intestinal mucosa plays a fundamental role as the site for absorption of nutrients, and as an important barrier from potentially harmful agents in the intestinal lumen. Little is known of the permeability properties of the intestinal mucosa in uraemic patients. The intestinal permeability to differently sized polyethylene glycols (PEGs; range 326-1254 daltons) was studied in nine patients with chronic renal failure (24 hour endogeneous creatinine clearance 5-24 ml/minute). The maximum 24 hour urinary recovery of PEGs was decreased in the uraemic patients but relatively more of the larger than the smaller PEGs were found in these patients. The results suggest a reduced urinary recovery of PEGs caused by renal dysfunction but also a relatively increased intestinal permeability to larger PEGs in the uraemic patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1855681      PMCID: PMC1378990          DOI: 10.1136/gut.32.7.754

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  40 in total

1.  Intestinal permeability tests: are they clinically useful?

Authors:  C H Lifschitz; R J Shulman
Journal:  J Pediatr Gastroenterol Nutr       Date:  1990-04       Impact factor: 2.839

2.  The duodenal mucosa in patients with renal failure: response to 1,25(OH)2D3.

Authors:  D A Goldstein; R E Horowitz; S Petit; B Haldimann; S G Massry
Journal:  Kidney Int       Date:  1981-02       Impact factor: 10.612

3.  Intestinal permeability.

Authors:  C Lifschitz
Journal:  J Pediatr Gastroenterol Nutr       Date:  1985-08       Impact factor: 2.839

4.  Bacterial populations of the small intestine in uremia.

Authors:  M L Simenhoff; J J Saukkonen; J F Burke; L G Wesson; R W Schaedler; S J Gordon
Journal:  Nephron       Date:  1978       Impact factor: 2.847

5.  The double sugar test of intestinal permeability in the elderly.

Authors:  W M Saweirs; D J Andrews; T S Low-Beer
Journal:  Age Ageing       Date:  1985-09       Impact factor: 10.668

6.  Intestinal permeability in healthy and allergic children before and after sodium-cromoglycate treatment assessed with different-sized polyethyleneglycols (PEG 400 and PEG 1000).

Authors:  K Fälth-Magnusson; N I Kjellman; K E Magnusson; T Sundqvist
Journal:  Clin Allergy       Date:  1984-05

7.  PEG 400, a hydrophilic molecular probe for measuring intestinal permeability.

Authors:  T Y Ma; D Hollander; P Krugliak; K Katz
Journal:  Gastroenterology       Date:  1990-01       Impact factor: 22.682

8.  Altered intestinal permeability to low-molecular-weight polyethyleneglycols (PEG 400) in patients with Crohn's disease.

Authors:  K E Magnusson; T Sundqvist; R Sjödahl; C Tagesson
Journal:  Acta Chir Scand       Date:  1983

9.  Passage of molecules through the wall of the gastrointestinal tract. Urinary recovery of different-sized polyethylene glycols after intravenous and intestinal deposition.

Authors:  C Tagesson; R Sjödahl
Journal:  Scand J Gastroenterol       Date:  1984-05       Impact factor: 2.423

10.  Passage of molecules through the wall of the gastrointestinal tract. II. Application of low-molecular weight polyethyleneglycol and a deterministic mathematical model for determining intestinal permeability in man.

Authors:  T Sundqvist; K E Magnusson; R Sjödahl; I Stjernström; C Tagesson
Journal:  Gut       Date:  1980-03       Impact factor: 23.059

View more
  44 in total

1.  Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD.

Authors:  Ruben Poesen; Ali Ramezani; Kathleen Claes; Patrick Augustijns; Dirk Kuypers; Ian R Barrows; Jagadeesan Muralidharan; Pieter Evenepoel; Björn Meijers; Dominic S Raj
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-07       Impact factor: 8.237

2.  Uremia induces upregulation of cerebral tissue oxidative/inflammatory cascade, down-regulation of Nrf2 pathway and disruption of blood brain barrier.

Authors:  Wanghui Jing; Bahman Jabbari; Nosratola D Vaziri
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

Review 3.  Gut Microbiome in Chronic Kidney Disease.

Authors:  R G Armani; A Ramezani; A Yasir; S Sharama; M E F Canziani; D S Raj
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

Review 4.  Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies.

Authors:  Wei Pan; Yongbo Kang
Journal:  Int Urol Nephrol       Date:  2017-08-28       Impact factor: 2.370

5.  Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease.

Authors:  Nosratola D Vaziri; Jun Yuan; Keith Norris
Journal:  Am J Nephrol       Date:  2012-12-19       Impact factor: 3.754

Review 6.  The gut microbiome, diet, and links to cardiometabolic and chronic disorders.

Authors:  Judith Aron-Wisnewsky; Karine Clément
Journal:  Nat Rev Nephrol       Date:  2015-11-30       Impact factor: 28.314

7.  Measurement of the intestinal permeability in chronic kidney disease.

Authors:  Matty L Terpstra; Ramandeep Singh; Suzanne E Geerlings; Frederike J Bemelman
Journal:  World J Nephrol       Date:  2016-07-06

Review 8.  The gut microbiome, kidney disease, and targeted interventions.

Authors:  Ali Ramezani; Dominic S Raj
Journal:  J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 10.121

9.  Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden.

Authors:  Jason R Stubbs; John A House; A Jacob Ocque; Shiqin Zhang; Cassandra Johnson; Cassandra Kimber; Kyle Schmidt; Aditi Gupta; James B Wetmore; Thomas D Nolin; John A Spertus; Alan S Yu
Journal:  J Am Soc Nephrol       Date:  2015-07-30       Impact factor: 10.121

10.  Oral activated charcoal adsorbent (AST-120) ameliorates chronic kidney disease-induced intestinal epithelial barrier disruption.

Authors:  Nosratola D Vaziri; Jun Yuan; Mahyar Khazaeli; Yuichi Masuda; Hirohito Ichii; Shuman Liu
Journal:  Am J Nephrol       Date:  2013-05-15       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.